Description
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
CV70 is a 1,8-Diaza-anthracene-tetrone compound that exhibits anticancer activity in vitro, inhibiting the activation of JNK and ERK5.
| Purity | ≥70% |
|---|---|
| Formula | C16H14N2O4 |
| Formula Wt. | 298.29 |
| Appearance | Red Powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| MSDS | |
|---|---|
| Info Sheet | |
| Brochures |
Pipaón C, Gutierrez P, Montero JC, et al. Mitogen-activated protein kinase routes as targets in the action of diaza-anthracene compounds with a potent growth-inhibitory effect on cancer cells. Mol Cancer Ther. 2002 Aug;1(10):811-9. PMID: 12492114.
Isoleucyl-tRNA synthase inhibitor, osteoclast p...
Mycotoxin found in Aspergillus and Penicillum; ...
Galactose analog, allolactose mimic, induces ac...
Chloramphenicol derivative; protein translation...
Vitamin D2, ergocalciferol metabolite; VDR agon...
Sesquiterpene lactone derived from Artemesia.
Peptide; α4β1 integrin activator.
Nucleoside (guanosine) analog; DNA chain termin...
SMAC mimetic; PXR agonist, IAP inhibitor.
JAK2 inhibitor.
DPP4 inhibitor.
Antineoplastic immunomodulator.
Thienylbutyl ITC analog.
Caffeic acid ester found in Melissa, Salvia, an...
Recombinant HIV-1 antigen fragment.
Triterpene; potential tyrosinase inhibitor.
TNKS1/2 inhibitor.
Echinocandin
VEGFR1/2/3, PDGFR, c-Kit, RET inhibitor.
β-lactamase inhibitor.